First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
布地加利单抗(一种抗PD-1抑制剂)在非小细胞肺癌和头颈部鳞状细胞癌患者中的首次人体I期研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-021-02973-w
Italiano, Antoine; Cassier, Philippe A; Lin, Chia-Chi; Alanko, Tuomo; Peltola, Katriina J; Gazzah, Anas; Shiah, Her-Shyong; Calvo, Emiliano; Cervantes, Andrés; Roda, Desamparados; Tosi, Diego; Gao, Bo; Millward, Michael; Warburton, Lydia; Tanner, Minna; Englert, Stefan; Lambert, Stacie; Parikh, Apurvasena; Afar, Daniel E; Vosganian, Gregory; Moreno, Victor